RankAlpha logo
Back to Rankings

RAPP

Rapport TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
RAPP vs peer average
33/100
RAPP vs. peer average (D vs. C)
Grade spread
A 3 · B 3 · D 2 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BHVN is the first available peer comparator.

Biohaven is the closest listed neuroscience-development comparator in the candidate set, though it is broader and better covered than Rapport; useful for how CNS pipeline optionality can move valuation ahead of registrational data.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBHVNBiohaven
RAPP
Rapport Therapeutics
BHVN
Biohaven
Grade
D
A
Momentum
78
72
Value
41
41
Sentiment
46
91
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs BHVN

RAPP / BHVN
Grade Position
Below peers
RAPP vs. peer average (D vs. C)
33/100
Momentum
78
RAPP
Value
41
RAPP
Sentiment
46
BHVN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RAPP
1
BHVN
BHVN
A
100/100
-3
2
DFTX
DFTX
F
20/100
+1
3
ORKA
ORKA
F
20/100
+1
4
OCUL
Ocular Therapeutix Inc Common
B
80/100
-2
5
MLYS
Mineralys Therapeutics Inc Common
B
80/100
-2
BHVN is the first peer returned for this comparison set.